FIA
MYOK

FNY Investment Advisers’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

FNY Investment Advisers’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-307
Closed -$15K – 1283
2019
Q2 		$15K Buy
+307
New +$14.9K ﹤0.01% 537

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FNY Investment Advisers's MYOK Position: Q3 2019 in Review

FNY Investment Advisers sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2019, closing a stake of 307 shares — an estimated $15K sold.

FNY Investment Advisers first reported a position in MYOK in Q2 2019 and held it in 1 quarter. The position peaked at $15K in Q2 2019. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

  • FNY Investment Advisers reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 307 MyoKardia, Inc. Common Stock shares in Q3 2019, an estimated $15K.
  • FNY Investment Advisers first reported a position in MyoKardia, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • FNY Investment Advisers's MyoKardia, Inc. Common Stock position peaked at $15K in Q2 2019.
  • 157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on FNY Investment Advisers's 13F filing for Q3 2019, filed 25 Oct 2019.